Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumours.

Histopathology - 1 Oct 2024

McHenry Austin, Devereaux Kelly, Ryan Emily, Chow Stephanie, Allard Grace, Ho Chandler C, Suarez Carlos J, Folkins Ann, Yang Eric, Longacre Teri A, Charu Vivek, Howitt Brooke E

Abstract excerpt

AIMS: Molecular classification according to The Cancer Genome Atlas (TCGA) improves endometrial endometrioid carcinoma (EEC) prognostication and has specific treatment implications; however, original data were skewed towards low-grade and low-stage tumours. Herein, we molecularly classify EECs metastatic at the time of diagnosis or with subsequently documented recurrent/metastatic disease to examine correlation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Immunohistochemistry

Share to Microsatellite Instability

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Poly-ADP-Ribose Binding Proteins

Source

Identifiers

PMID: 38859768
DOI: 10.1111/his.15232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumours.PMID 38859768Read ↗

Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study.Semantic proximity Read ↗

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.Semantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.Semantic proximity Read ↗

Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Semantic proximity Read ↗

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.Semantic proximity Read ↗

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial CarcinomasSemantic proximity Read ↗

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.Semantic proximity Read ↗

Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer.Semantic proximity Read ↗

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read ↗

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment.Semantic proximity Read ↗

High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.